Lupin LTD

Lupin one of top 6 pharma companies in India. USFDA, UKMHRA, TGA Australia accrd; is leading player in of Anti-TB, Cephalosporins, and cardiovascular medicine. 50 countries - US, Europe, Japan and Australia, Today has many ANDA's filed in US and European markets. Contact Venkatesh Nallamchetty - Sr. manager - Business Development. Cell: +919833522005 email - venkateshnallamchetty@lupinpharma.com

Activity:

- Clinical Trials
- Contract Manufacturing
- Contract Research
- Licensing & Business Development
- Manufacturing
- Research & Development
- Sales & Distribution

Product / Technology type(s) covered:

- API / chemicals
- Bio
- Drug delivery
- Generics
- FP (finished products)
- NCE (new chemical entities)
- OTC (over the counter drugs)
- Pharmaceuticals / Therapeutics
- Nutritionals / Vitamins
- Prescription drugs (Rx)
- Technology

Therapeutic targets:

- Aging
- AIDS
- Allergy
- Alzheimer's Disease
- Arthritis / Rheumato
- Asthma
- Cancer
- Cardiovascular
- Central nervous system
- Cough / Cold
- Dermatology
- Diabetes
- Epidemiology
- Gastrointestinal
- Genetics
- Geriatrics
- Hematology
- Infectious Diseases
- Men's Health
- Mental Health
- Neurology
- Obesity
- Oncology
- Ophthalmology
- Pain
- Pediatrics
- Reproductive Health
- Respiratory Medicine
- Stroke
- Urology
- Women's Health

Markets Covered

a. HeadQuarter: India

b. Continent(s) active: North America , Europe , Near/Middle East , Far East , Central/South America , Africa , Asia , Australia/New-Zealand

c. Countries active: USA, France, Gernmany, Mexico, Brazil, South Africa, Philippines, CIS, Africa, Philippines, Malaysia.

Corporate data:

Number of Employees: 3000

Turnover:

Amount:	Year:	Currency:
450000000	2005	US Dollar

Year founded: 1968

Stock options:

	Symbol	Exchange
1	LUP	1500

Partners / Alliances: various